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Respiratory medicine is the subspecialty
in medicine which requires the most regu-
lar and precise evaluation of physiological
function for complete assessment of the
patient. The very nature of respiratory
physiology requires the availability of a
range of technological devices.
Physiological measurements that may be
required in a patient undergoing assess-
ment for respiratory disease include pul-
monary function tests of varying complex-
ity, measurement of arterial blood gases
and pH, exercise testing, various forms of
bronchial provocation testing, and the
evaluation of sleep. These measurements
have been possible for a number of years
and require a considerable knowledge of,
and investment in, technology.
Lung volume measurements were first
made in the 17th century and measure-
ments of respiratory mechanics and
breathing function were accomplished in
the early 19th centur y. John Hutchinson
is credited with the first assessment of
breathing function in 1846 using a device
called a spirometer, which allowed mea-
surement of inhaled and exhaled volumes.
Respiratory physiology and many of the
important measurable variables were
established using a series of tubes, bal-
loons, spirometers, glassware and chemi-
cal measuring techniques. Respiratory
physiology laboratories, even into the
1980s, contained many interesting water-
sealed and dry-seal spirometers, dry gas
meters, Douglas bags, meteorologic bal-
loons, chart recorders and other devices
dragooned into service for pulmonary
function and exercise testing.
The onset of the computer era in the late
20th century has revolutionised pul-
monary physiology. Technological
advances have made measurement of
many pulmonary function and other phys-
iological variables available to many out-
side the dedicated respiratory physiology
laboratory. These advances include the
dramatic increase in computer processing
power and the ready availability of com-
puters, and miniaturisation made possible
by advances in integrated circuit technolo-
gy. Bulky water-seal (Fig. 1) or dry-
rolling-seal spirometers have been
replaced by compact pneumotachographs
of varying designs (Fig. 2), and gas analy-
sers can now provide continuous and
nearly instantaneous results. Complex
pulmonary function tests, exercise tests,
gas and blood gas analysis and sleep stud-
ies are now available with equipment not
much larger than desktop computers. The
result has been an explosion in the num-
ber of devices designed for testing and a
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critical care and sleep
medicine as well as
orienteering, road
running and cycling. 
Technology in respiratory
medicine
New technological developments mean that 
respiratory function can be measured by family
p h y s i c i a n s .
Fig.1. A typical bulky water-sealed spirometer.
Spirometry traces were drawn on paper dur-
ing respiratory efforts and then measured
manually using a ruler and calibration traces.
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massive increase in the availability
of complex physiological measure-
ments. There are both positive and




These include advantages for the
requesting clinician as well as for
the technologist tasked with per-
forming the test. Many of the
early pulmonary function testing
systems required laborious calibra-
tion before each use, often leading
to omission of this essential step
with resultant loss of accuracy in
the measurements made. This was
highlighted by Basson and Stewart1
in 1991, who researched the ques-
tion of spirometer use in 45 med-
ical practices and found that only 6
regularly calibrated the spirometer.
Forced vital capacity was under- or
over-recorded by between 6% and
30% in 14 instances.1 Guidelines
published by the American
Thoracic Society regarding the
performance of spirometry have
resulted in most systems now
requiring at least daily calibration
before use or a warning statement
on results that calibration has not
been recently performed.2
Automation of many tasks such as
valve switching means that more
precise timing is possible and the
technologist is able to concentrate
on the performance of the required
manoeuvre by the subject, rather
than on the equipment. This
allows better coaching and early
correction of errors of performance
by the subject. Better interaction
between the technologist and the
subject without equipment-related
distractions should allow for better
reproducibility and reliability of
efforts. Computer-driven testing
protocols ensure that testing is
more standardised and many tests
have criteria for adequacy of mea-
surement  built into them and the
system will recommend rejection of
data. Correction factors such as
BTPS and ATPS are automatically
programmed into the calculations
ensuring compliance with usual
conventions for reporting of
results.
Results are rapidly available and
calculations are accurately per-
formed with transcription errors
kept to a minimum. Computer-
generated standard reference val-
ues (provided values appropriate
for the population being tested are
chosen) are also readily available,
improving the reliability of inter-





not always beneficial and those
related to pulmonary function test-
ing are no exception. Testing
equipment has now become a
‘black box’ — gas and other sam-
ples are taken in and measured and
results are produced. Data trans-
parency is reduced as the data
entered into calculations are usual-
ly not available, the algorithms
behind the calculations are some-
times obscure or not well validated
and neither the technologist nor
the clinician has the capacity to
easily adjust obviously incorrect
results. The phenomenon of
‘garbage in, garbage out’ is very
prevalent in automated testing sys-
tems and requires vigilance on
behalf of the clinician to detect
this. Report formats are often
unwieldy and difficult to reformat.
Frequently many variables of dubi-
ous relevance are produced and
their profusion may divert atten-
tion from those that are clinically
most important.
A serious drawback to automated
systems is the reduced understand-
ing of what is being measured and
how actions by the subject or the
technologist might influence these.
Measurement of gas exchange at
rest and during exercise are partic-
ularly prone to this type of prob-
lem. Averaging and smoothing of
data that occurs with many systems
can obscure important events.
Many advances in respiratory and
exercise physiology have been
made serendipitously with unusual
recordings prompting an explo-
ration of the underlying phenome-
na. The rigid and proprietary
analysis algorithms employed in
most modern systems make it
impossible to customise or adapt
equipment to undertake any tests
that are not directly available in the
system.
Further disadvantages include the
rapid obsolescence of equipment
with progress in other areas, often
causing otherwise functioning sys-
tems to become useless as the abil-
ity to interface data input or soft-
ware with new computer hardware
Fig. 2. A modern unheated pressure-
drop pneumotachograph which
requires only attachment to a person-
al computer loaded with the appropri-
ate software.
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or operating systems may be lost.
Further expense often results from
inflexible designs. In times gone
by, exercise testing and sleep stud-
ies were performed using the same
equipment by day and night.
Current technology requires sepa-
rate systems which are mutually
incompatible to perform these
tests.
THE ROLE OF THE CLINI-
CAL TECHNOLOGIST
As the name suggests, the clinical
technologist should be the inter-
face between the subject to be test-
ed, the testing apparatus, and the
clinician. The training of a clinical
technologist is in performing the
various respiratory physiology tests
and this requires knowledge of the
mechanics of the test, calibration
and use of the apparatus used for
testing, and most importantly,
coaching of the subject in the tech-
niques to be used, supervision of
the test, and correction of subject-
induced errors in test performance.
The attributes of a good clinical
technologist, apart from knowledge
of the pure technological side of
the task, are:
• an ability to handle a wide range
of people and empathically
explain manoeuvres  
• the ability to recognise incorrect
results and repeat the test before
the subject leaves the testing
environment 
• a cynical, but insightful, distrust
of results produced by physiolo-
gy testing equipment with the
willingness to troubleshoot by
repeated calibration and testing
until satisfied that the results are
as good as can be obtained.
THE ROLE OF RESPIRA-
TORY TECHNOLOGY IN
CLINICAL MEDICINE
The formidable array of technolo-
gies available and many of the
technical considerations might sug-
gest that respiratory physiology and
the technology used for measure-
ment of various values should be
kept in the specialist physiology
laboratory and not unleashed on
the general population. This is
probably true for a number of
areas, including measurement of
subdivisions of lung volumes, dif-
fusing capacity, gas exchange, exer-
cise testing, and sleep studies.
However, the improvements in
technology outlined above have
made spirometers widely available,
user-friendly and reasonably
priced. There can be no excuse for
the spirometer not moving into the
practitioner’s consulting room
alongside items such as the stetho-
scope and otoscope. Abnormal
spirometric values are well recog-
nised as an indicator of morbidity
and increased mortality.
Spirometry basically measures air-
flow out of fully inflated lungs.
Historically, spirograms were
recorded by measuring volume and
recording this against time.
Modern devices more usually con-
sist of some form of pneumotacho-
graph and record flow against
time. Integration of this signal
produces volume and so it is possi-
ble to produce both volume-time
plots and flow-volume curves. The
important measurements for clini-
cal and epidemiological practice
are those derived from the volume-
time curve (Fig. 3) and these are
the forced vital capacity (FVC) —
the maximum volume of gas
exhaled after a maximal inspiration
— and the forced expiratory vol-
ume in 1 second (FEV1) — the
volume of gas exhaled in the first
second of the FVC manoeuvre.
The ratio FEV1/ FVC is of great
importance in diagnosis and is
usually expressed as a percentage.
The e x p i r at o ry flow - volume curve
(Fi g . 4 ) has become increasingly
widely used and a number of more
complex values can be measured
from this. These include the peak
expiratory flow rate (PEFR), which
should be achieved within 0.1 sec-
onds of starting the expiratory
effort, and other values such as the
forced expiratory flow between
25% and 75% of FVC (FEF25-75%).
These more complex measures do
not have much clinical relevance
but are important in the more pre-
cise research world. The coeffi-
cient of variation in measurements
such as FEF25-75% is reasonably large
and considerable discretion is
required in their use.
The values recorded during a
forced expiratory manoeuvre
depend upon the elastic recoil of
lungs and chest cage, and small
and large airways function. An
important point is that although
the initial part of a forced exhala-
tion from maximal inspiration is
effort dependent, it  becomes
much less dependent upon effort
Fig. 3. An example of a normal vol-
ume-time plot.  FEV1 is measured
where the volume trace crosses the
vertical line up from 1 second after
onset of exhalation, FVC is measured
as the plateau achieved after com-
plete exhalation.
Fig. 4. An example of a normal expira-
tory flow-volume curve.  FVC is the
volume exhaled during the expiratory
effort but FEV1 cannot be measured
directly from the flow-volume curve
and must be obtained from a syn-
chronous volume-time curve.
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once approximately 20% of the
vital capacity has been exhaled. It
is this property that makes the
FVC and FEV1 reliable measure-
ments with low coefficients of vari-
ation compared with many other
measures of pulmonary function.
Full inspiratory manoeuvres and
maximum expiratory effort are
important for ensuring repro-
ducible results.
The South African Thoracic
Society Guide for Office
Spirometry to be published shortly
includes the following as indica-
tions for spirometry:
• confirmation of diagnosis of
obstructive or restrictive lung
disease
• monitoring change in health sta-
tus in those with chronic respi-
ratory disease or in occupations
that are exposed to injurious
substances
• grading respiratory impairment
for assessing the need for or
intensity of treatment, or for
medicolegal evaluations, or for
preoperative evaluation prior to
thoracic or upper abdominal
surgery
• screening for lung disease
among smokers, those with per-
sistent respiratory symptoms,
prior to employment in those
with potential for exposure to
hazardous substances, or in





Spirometers may be of the volume-
accumulating or flow-measuring
type but should be validated
according to minimal performance
criteria laid down by the American
Thoracic Society.2 Important
points include accuracy over a
range of volumes and flow rates,
the ability to produce real-time
graphs, computer-driven quality
indicators, ability to print records,
and ease of calibration procedure.
The most important factors in
ensuring reproducible and accurate
results are human. The operator
(ideally a clinical technologist or
other individual who has under-
gone appropriate training) must
understand the principles of testing
and equipment operation and must
be able to explain clearly the
manoeuvres required of the subject
to be tested.
The subject must be seated com-
fortably and then instructed to
inhale fully and then forcibly
exhale into the mouthpiece of the
apparatus for as long as possible.
Repeated explanation, encourage-
ment, and demonstration are help-
ful as maximum efforts ensure
reproducible results. A nose clip
may be useful in some instances.
Common problems in producing
acceptable efforts include leaks at
the mouth or nose, protrusion of
the tongue into the mouthpiece,
coughing, and attempts to breathe
in before full exhalation is com-
pleted.
A technically acceptable attempt
has distinct features on the flow-
volume or volume-time curve pro-
duced by the apparatus. These
include no hesitation at start of
exhalation with a rapid rise in flow
rate, PEFR reached within the first
15% of FVC (if a flow-volume
curve is displayed), and the exhala-
tion must be smooth without
coughs, gasps or second breaths.
Expiration should last at least 6
seconds or until a plateau in vol-
ume or zero flow is reached (this
may take up to 15 seconds in indi-
viduals with severe airflow obstruc-
tion). At least 3 technically accept-
able attempts should be recorded.
Efforts are deemed reproducible
when the values for FVC and FEV1
on at least 2 attempts are within
100 ml or 5%.
INTERPRETATION OF
SPIROMETRY RESULTS
Pulmonary function in health
varies with age, stature and gender.
There are a number of prediction
equations available and it is impor-
tant that the equations chosen or
programmed into the spirometer
reporting system are appropriate
for the population under investiga-
tion. In general we have found
that the reference equations pro-
duced by the European
Community for Coal and Steel
(ECCS)3 produce reference values
that are acceptable for our popula-
tion in Cape Town. The question
of adjustment for ancestry is con-
troversial with some authors rec-
ommending an adjustment of
between –10 and –13% for individ-
uals not of European descent.
The interpretation of spirometry
results is aimed at establishing the
underlying disease process and
then assessing severity. The most
important value in terms of parti-
tioning the disease process into
obstructive or non-obstructive is
the FEV1/ FVC ratio. A value of
less than 70% is indicative of an
obstructive process such as asthma
or chronic obstructive pulmonary
disease (COPD). Distinction
between asthma and COPD may
be made by repeating the spiro-
metric testing after administration
of a short-acting inhaled beta-2
agonist bronchodilator such as
salbutamol. An improvement in
FEV1 of 12% and at least 200 ml is
regarded as  significant.
A normal FEV1/ FVC ratio with
reduced FVC is suggestive of a
restrictive ventilatory disorder.
Common causes of this include the
interstitial lung diseases such as
idiopathic interstitial pneumonitis
or sarcoidosis, pneumoconiosis,
chest cage or vertebral deformity,
respiratory muscle weakness, or
previous destructive lung disease
such as tuberculosis. Severity is
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usually graded compared with pre-
dicted values and a suggested




Obstructive lung diseases such as
asthma and COPD affect a consid-
erable proportion of the popula-
tion, between them at least 10% of
adults. Cost-effective use of the
available treatment options for
these conditions is totally depen-
dent upon accurate assessment of
the severity of the disease and then
ongoing monitoring. International
efforts such as the Global Initiative
for Asthma (GINA) and Global
Initiative for Chronic Obstructive
Lung Disease (GOLD), along with
guidelines issued by regional tho-
racic societies, emphasise the role
of pulmonary function testing, par-
ticularly spirometry, in the assess-
ment and effective management of
these conditions. The guidelines of
the South African Thoracic Society
for the management of chronic
asthma,4 and for COPD5 (recently
revised but not yet published), also
emphasise the fact that it is impos-
sible to reliably make these diag-
noses or to institute effective man-
agement in the absence of ade-
quate spirometric testing.
Attempting to manage obstructive
airways disease with anti-inflam-
matory and bronchodilatory drugs
without spirometry has been
likened to trying to manage dia-
betes without measuring blood glu-
cose or to administer warfarin
without monitoring the INR.
Assessment of asthma control his-
torically has often depended upon
health care worker or patient evalu-
ation of a single or a limited num-
ber of end-points such as PEFR or
symptoms. The advances in com-
puter technology and the availabili-
ty of reliable and reasonably priced
portable spirometers have opened
new opportunities for remote or
computer-assisted guideline man-
agement of obstructive lung dis-
ease.6 Home spirometry measure-
ments (PEFR or FEV1) and elec-
tronic asthma diary recordings can
be downloaded via a modem to a
monitoring system. Deviations
outside preset parameters will alert
a programme co-ordinator who
can then contact the patient or the
patient’s physician about the
changes and suggest appropriate
guideline-based alterations to
maintenance treatment. This type
of system has been shown to
reduce overall health care expendi-
ture in pilot studies.
CONCLUSION
New technologies in respiratory
medicine have opened exciting
doors for more effective patient
management by making previously
complex measurements available in
user-friendly and compact equip-
ment. User-friendly, however, does
not remove the need for appropri-
ate training in the use of such
equipment. Calibration, proper
setup, effective patient coaching
and ensuring that tests meet
applicable standards, are still
essential. The cost of acquiring
and maintaining equipment, along
with the need to purchase and
store special gas mixtures for more
sophisticated respiratory physiology
tests, means that these will remain
in the domain of  specialised respi-
ratory services and continue to be
performed by clinical technolo-
gists.
References available on request.
Websites
Global Initiative for Asthma (GINA):
http://www.ginasthma.com
Global initiative for Chronic Obstructive Lung Dis-
ease (GOLD): http://www.goldcopd.com
Normal Mild Moderate Severe
FEV1 ≥ 80% 60 - 79% 41 - 59% ≤ 40%
FVC ≥ 80% 60 - 79% 51 - 59% ≤ 50%
Table I. Guide for grading spirometric abnormalities
based on percentage of predicted value
IN A NUTSHELL
Te c h n o l o g i cal advances have
allowed complex re s p i r a t o ry physiol-
ogy measurements to be made out-
side of dedicated pulmonary func-
tion laboratories.
Office spiro m e t ry is an essential
component of the effective manage-
ment of re s p i r a t o ry disease, part i c u-
larly asthma and COPD .
S p i rometers for consulting room use
need to conform to technical sta n-
d a rds recommended by the
A m e r i can Thoracic Society.
Regular calibration of all pulmonary
function testing is mandatory.
The most reliable results from pul-
m o n a ry function tests are obta i n e d
when the operator is a qualified clin-
i cal technologist or has underg o n e
a p p ropriate training in the tests to
be perf o r m e d .
Reliable spiro m e t ry results re q u i re
maximum inspiratory and expiratory
e f f o rts and technically accepta b l e
c u rves.  At last 3 acceptable curv e s
a re necessa ry and at least 2 should
have re p roducible values.
Re f e rence values that have been
d e m o n strated to be applicable to
the population under study should
be used.  The ECCS re f e rence equa-
tions are generally appropriate for
South African use although an
allowance may need to be made for
individuals of non-European ances-
t ry.
Complex pulmonary function and
e x e rcise tests should be re s e rv e d
for dedicated re s p i r a t o ry physiology
laboratories as specialised test i n g
gases, more complex equipment
and appropriately trained and quali-
fied staff are essential.
